Tag

india Archives | Page 11 of 153 | Smartkarma

Daily Brief India: Urban Company, Mahindra & Mahindra, Amber Enterprises India, Amanta Healthcare and more

By | Daily Briefs, India

In today’s briefing:

  • Urban Company IPO – Thoughts on Valuations – Not a Whole Lot of Upside
  • Mahindra & Mahindra (MM IN) | Pricey Patriotism or Desperation?
  • Amber Enterprises: Implication of Rs 1,200 Crore Infusion in Iljin Electronics from PE
  • Urban Company IPO – Beauty-Led Platform With Structural Growth Tailwinds
  • The Beat Ideas: Amanta Healthcare IPO – Navigating Growth in the Sterile Pharma Space.


Urban Company IPO – Thoughts on Valuations – Not a Whole Lot of Upside

By Sumeet Singh

  • Urban Company (UCL IN) is looking to raise about US$220m in its upcoming India IPO.
  • UCL is a tech-enabled platform offering home and beauty services delivered by trained professionals at customer’s location.
  • We have looked at the past performance in our previous note. In this note, we talk about the IPO pricing.

Mahindra & Mahindra (MM IN) | Pricey Patriotism or Desperation?

By Pranav Bhavsar

  • Mahindra & Mahindra (MM IN) pre-announces GST benefits, signaling consumer-first patriotism but raising questions on intent.
  • Dealer checks reveal heavy discounting despite festive demand hopes coupled with weak dispatches.
  • Possible margin risks emerge as MM tries to flush out inventory ahead of GST 2.0 and festive season.

Amber Enterprises: Implication of Rs 1,200 Crore Infusion in Iljin Electronics from PE

By Nimish Maheshwari

  • Amber Group’s electronics arm, ILJIN Electronics, has raised Rs 1,200 crore in its first-ever institutional fundraise, led by private equity firm ChrysCapital and supported by InCred Growth Partners.
  • This capital infusion accelerates ILJIN’s organic expansion & supports its strategic inorganic growth ambitions, positioning the company as key beneficiary of India’s push for self-reliance under PLI and ECMS schemes.
  • The fundraise is a powerful validation of Amber’s strategic pivot towards high-growth EMS sector, paving the way for sustained, multi-year growth and a potential re-rating of the consolidated entity.

Urban Company IPO – Beauty-Led Platform With Structural Growth Tailwinds

By Rahul Jain

  • Urban Company is India’s largest organized online home-services platform, with ~60% of revenues from Beauty & Wellness and dominant market share across categories.
  • IPO proceeds (~₹4,720 mn fresh issue) will be used to strengthen technology, expand professional training, enhance branding, and fund working capital.
  • The platform connects customers with vetted professionals for beauty, cleaning, repairs, and home improvement, differentiated by its supply-controlled model (training, kits, quality standards).

The Beat Ideas: Amanta Healthcare IPO – Navigating Growth in the Sterile Pharma Space.

By Nimish Maheshwari

  • The company operates a diversified portfolio of sterile liquid products across six therapeutic segments, with a strong domestic presence and expanding global reach, ensuring consistent revenue streams. 
  • Proceeds from the IPO will fund the establishment of two new sterile manufacturing lines, significantly enhancing SteriPort and SVP capacities, expected to drive growth in FY26-27. 
  • While the IPO valuation appears elevated at 46x FY25earnings, the company’s debt reduction and expanded capacity should lead to moderated multiples.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Blue Jet Healthcare Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • Blue Jet Healthcare: Pureplay Intermediates CDMO. Recent Correction Overdone, Good for Fresh Bet


Blue Jet Healthcare: Pureplay Intermediates CDMO. Recent Correction Overdone, Good for Fresh Bet

By Himanshu Dugar

  • BLUEJET is a pure-play API/CDMO with strong positioning in contrast media intermediates. Further, it has demonstrated R&D and execution capabilities by commercialising 15+ molecules (oncology, CVS, CNS) under CDMO model.
  • Its share price has corrected by ~35% since July end, after below expectation June quarter results exacerbated by weak export data amid tariff concerns. However, August numbers alleviated some concerns.
  • Shares now trade at 30x FY26 PE, the lower end of 30-60x range where peers currently trade at. Company has high visibility for 20+% earnings growth for the medium term.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Kotak Mahindra Bank, Newgen Software Technologies and more

By | Daily Briefs, India

In today’s briefing:

  • Long Kotak Mahindra (KMB IN) Vs. Short Bajaj Finance (BAF IN): Statistical Arbitrage in Indian Banks
  • Newgen Software Technologies- Forensic Update


Long Kotak Mahindra (KMB IN) Vs. Short Bajaj Finance (BAF IN): Statistical Arbitrage in Indian Banks

By Gaudenz Schneider

  • Context: The Kotak Mahindra Bank (KMB IN) vs. Bajaj Finance (BAF IN) price-ratio has deviated more than two standard deviations from its one-year average, presenting a potential relative value opportunity.
  • Highlights: Going long Kotak Mahindra Bank (KMB IN) and short Bajaj Finance (BAF IN) targets a 9% return, with the long position supported by cheaper valuations.
  • Why Read: Essential for quantitative traders seeking mean-reversion opportunities, with detailed execution framework, risk management protocols, and historical simulation showing the statistical basis for this relative value play.

Newgen Software Technologies- Forensic Update

By Nitin Mangal

  • Newgen Software Technologies (NEWGEN IN) is the leading provider of a unified digital transformation platform with native process automation, content services, and communication management capabilities.
  • The company continues to exhibit aggressive accounting practice in FY25, where growth driven by overseas subsidiaries was majorly tied up in credit period. Higher provision on debtors is further concerning. 
  • High remuneration to promoters and independent directors, insider trading complaints, are few governance concerns

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Urban Company, JTEKT India, SGX Rubber Future TSR20, Apollo Hospitals Enterprise and more

By | Daily Briefs, India

In today’s briefing:

  • Urban Company IPO – Hyperlocal SME Services Increases Disintermediation Risk
  • Business Breakdown: JTEKT India – Can Maruti EV Accelerate a Structural Rerating?
  • India Synthetic Rubber Demand On Import Leash As Tariffs Begin Biting
  • Apollo Hospitals (APHS IN): Starts FY26 on Strong Footing; Eyes Double-Digit Revenue Growth for FY26


Urban Company IPO – Hyperlocal SME Services Increases Disintermediation Risk

By Sumeet Singh

  • Urban Company(UC) is looking to raise about US$220m in its upcoming India IPO. 
  • UCL is a tech-enabled platform offering home and beauty services delivered by trained professionals at customer’s location.
  • In this note, we look at the company’s past performance.

Business Breakdown: JTEKT India – Can Maruti EV Accelerate a Structural Rerating?

By Sudarshan Bhandari

  • JTEKT India outpaced industry growth in FY25 with CVJ commercialization and a 100% system supplier role for Maruti’s upcoming EV
  • Strong OEM stickiness and global hub positioning provide revenue visibility, but heavy capex and margin compression weigh on near-term returns. 
  • Growth remains structurally intact, but the story shifts to a transition phase, earnings quality and capital efficiency will stay constrained until FY27.

India Synthetic Rubber Demand On Import Leash As Tariffs Begin Biting

By Vinod Nedumudy

  • SR demand in FY 2025 surges 9.3%, outpacing 6.1% rise in output  
  • Imports rise nearly 17% YoY to 413,627 tons in FY 2024-25  
  • Reclaimed Rubber consumption up 8.55% to 167,500 tons  

Apollo Hospitals (APHS IN): Starts FY26 on Strong Footing; Eyes Double-Digit Revenue Growth for FY26

By Tina Banerjee

  • Apollo Hospitals Enterprise (APHS IN) delivered robust performance in Q1FY26, with double-digit revenue growth across all three business verticals and continuous margin expansion.
  • Hospital business revenue grew 11% YoY to INR29B, driven by inpatient volume (+3%) and favorable price and case mix (+8%). Margin improvement continued, with EBITDA margin expanding 88bps to 24.5%.
  • Apollo anticipates continued double digit revenue growth for FY26, underpinned by strong performance of the existing hospitals and new hospital openings.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Tata Capital Limited, Mahindra & Mahindra, Jindal Steel and more

By | Daily Briefs, India

In today’s briefing:

  • Tata Capital Pre-IPO – The Negatives – Recent Merger Wasn’t All that Great
  • A Trader’s Guide To “G” Day | Positioning For “Next-Generation GST Reforms”
  • Jindal Steel – Transition Analysis


Tata Capital Pre-IPO – The Negatives – Recent Merger Wasn’t All that Great

By Sumeet Singh

  • Tata Capital Limited (TATACAP IN) is looking to raise up to US$2bn in its upcoming India IPO.
  • Tata Capital Limited (TCL) is the flagship financial services company of the Tata group and a subsidiary of Tata Sons Private Limited.
  • In this note, we talk about the not-so-positive aspects of the deal.

A Trader’s Guide To “G” Day | Positioning For “Next-Generation GST Reforms”

By Pranav Bhavsar

  • The 56th GST Council Meeting is currently underway in New Delhi, having commenced on September 3, 2025 at 11:00 AM and will continue until September 4, 2025.
  • These are supposed to be “next-generation GST reforms” with a promise of implementing reforms as a “Diwali gift” for consumers.
  • Negative FII Participation, Negative Price Action, Rich Multiples coupled with Negative Earnings Revisions argue for a bearish positioning going into the “G” Day – Day of GST Reform Announcements.

Jindal Steel – Transition Analysis

By Carbon Tracker Initiative

  • This is the third report in our series analysing the state and outlook for Indian steel majors in their ambition to expand capacity while meeting decarbonisation goals.
  • Following our reports on JSW Steel and Tata Steel, this edition focuses on Jindal Steel.
  • Jindal Steel has set a net zero emissions target for 2047, 23 years ahead of India’s national goal.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Tata Capital Limited, Molbio Diagnostics Limited and more

By | Daily Briefs, India

In today’s briefing:

  • Tata Capital Pre-IPO – The Positives – Will Ride High on the Brand Name
  • Molbio Diagnostics Limited Pre-IPO Tearsheet


Tata Capital Pre-IPO – The Positives – Will Ride High on the Brand Name

By Sumeet Singh

  • Tata Capital Limited is looking to raise up to US$2bn in its upcoming India IPO.
  • Tata Capital Limited (TCL) is the flagship financial services company of the Tata group and a subsidiary of Tata Sons Private Limited.
  • In this note, we talk about the positive aspects of the deal.

Molbio Diagnostics Limited Pre-IPO Tearsheet

By Hong Jie Seow

  • Molbio Diagnostics Limited (1788863D IN)  is looking to raise about US$229m in its upcoming India IPO. The deal will be run by Kotak, IIFL, Jefferies and Motilal.
  • Molbio specializes in point-of-care molecular diagnostics. The company sells hardware devices such as the Polymerase Chain Reaction (PCR) analyzers and consumable test kits tailored to detect specific diseases.
  • As of FY25, its revenue base remains primarily domestic, with ~80% of revenue from India and the rest from Nigeria, Bangladesh, and Indonesia. The company manufactures its products in India.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: National Aluminium, Akums Drugs and Pharmaceuticals and more

By | Daily Briefs, India

In today’s briefing:

  • The Beat Ideas: Nalco’s ₹30,000 Crore Expansion
  • Business Breakdown: Akums Drugs – Market Leader with Global Ambitions


The Beat Ideas: Nalco’s ₹30,000 Crore Expansion

By Sudarshan Bhandari

  • National Aluminium (NACL IN) has announced a significant INR 30,000 crore capex over the next five years, its largest in recent history, to expand its core smelting, power generation capabilities.
  • Targeting an almost doubling of its smelting capacity and securing long-term power supply. This is crucial for NALCO to enhance its competitiveness and achieve the coveted “Maharatna” status by 2030.
  • This expansion, funded by a mix of internal accruals and debt, positions NALCO for an earnings inflection point, contingent on disciplined execution and favorable long-term commodity cycles.

Business Breakdown: Akums Drugs – Market Leader with Global Ambitions

By Sudarshan Bhandari

  • Akums secured a €200m European supply contract, marking its first large entry into regulated markets and validating its compliance and scale capabilities.
  • This shifts Akums from a domestic CDMO leader to a credible global player, with exports positioned to become a material earnings contributor from FY27.
  • While near-term growth remains muted, Akums’ medium-term profile looks stronger, with greater diversification and reduced dependence on India’s CDMO cycle.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: InterGlobe Aviation Ltd and more

By | Daily Briefs, India

In today’s briefing:

  • Quiddity Leaderboard BSE ​​​​SENSEX Dec25: Tech Mahindra Likely to Escape Sensex Deletion


Quiddity Leaderboard BSE ​​​​SENSEX Dec25: Tech Mahindra Likely to Escape Sensex Deletion

By Janaghan Jeyakumar, CFA

  • BSE SENSEX represents the 30 largest stocks listed in the Bombay Stock Exchange (BSE) of India.
  • In this insight, we take a look at the Potential ADDs/DELs for the BSE SENSEX Index in the December 2025 index rebal event.
  • As things stand, there will be no index changes for the BSE SENSEX index.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Grasim Industries, OnEMI Technology Solutions, CleanMax Enviro Energy Solutions Ltd, Lumino Industries Ltd, NIFTY Index, Ola Electric and more

By | Daily Briefs, India

In today’s briefing:

  • Birla Opus Assurance: Marketing Wars at Play
  • OnEMI Technology Solutions (Kissht) Pre-IPO Tearsheet
  • CleanMax Enviro Energy Solutions Pre-IPO Tearsheet
  • Lumino Industries Limited Pre-IPO: Strong Momentum but Rising Risks Temper Outlook
  • NIFTY 50 Tactical View: Risk-Off Scenario Before Sep-30 Rebalance + Tariffs Impact
  • Ola Electric 2.0: From Scooters to Cells and Rare-Earth-Free Motors


Birla Opus Assurance: Marketing Wars at Play

By Nitin Mangal

  • Grasim Industries (GRASIM IN) ‘s Birla Opus rolled out “Birla Opus Assurance”— India’s first 1-year free repainting program covering various defects.
  • This is just another marketing technique, aimed at capturing market share from existing players. Because of the cut throat competition, other players are expected to launch similar programs.
  • Ultimately, this would lead to higher warranty provisioning as well as higher A&P spends, thereby impacting the margins. But in long run, we expect warranty claims to be modest.

OnEMI Technology Solutions (Kissht) Pre-IPO Tearsheet

By Hong Jie Seow

  • OnEMI Technology Solutions (1553346D IN) is looking to raise about US$172m in its upcoming India IPO. The bookrunners for the deal are JM Financial, HSBC, Nuvama, SBI Caps.
  • Also known as Kissht, its products include personal loans for salaried and self-employed individuals for consumption and business needs, and loans against property for asset-owning MSMEs and salaried individuals.
  • As of March 31, 2025, Kissht had 53.23m registered users, 9.16m customers, and INR 40,866m in AUM.

CleanMax Enviro Energy Solutions Pre-IPO Tearsheet

By Akshat Shah

  • CleanMax Enviro Energy Solutions Ltd (8382406Z IN) (CEESL) is looking to raise about US$570m in its upcoming India IPO. 
  • The deal, a combination of a fresh issue and an offer for sale, will be run by Axis, HSBC, IIFL, JPM, Nomura, BNP Paribas, Bob Caps and SBI Caps.
  • CEESL is a provider of commercial and industrial renewable energy, specializing in delivering decarbonization solutions, including supplying renewable power and offering energy services and carbon credit solutions to customers.

Lumino Industries Limited Pre-IPO: Strong Momentum but Rising Risks Temper Outlook

By Hong Jie Seow

  • Lumino Industries Ltd (0349204D IN) is looking to raise US$116m in its upcoming India IPO.
  • Lumino is an engineering, procurement, and construction (EPC) player in India, focusing on the manufacturing of conductors, power cables, electrical wires, and others for the power distribution and transmission industry
  • In this note, we look at the company’s past performance.

NIFTY 50 Tactical View: Risk-Off Scenario Before Sep-30 Rebalance + Tariffs Impact

By Nico Rosti

  • As forecasted in our previous insight, the NIFTY Index rallied past 25k, but we said this was a BEARISH pattern rally was short-lived (2 weeks), then this week down.
  • Effective September 30 InterGlobe Aviation (IndiGo) and Max Healthcare Institute will be added to the NIFTY, replacing Hero MotoCorp and IndusInd Bank, in the meanwhile 50% US tariffs kicked in.
  • We see a potential continuation of the recent bearishness with a RISK-OFF scenario where the index could drop to much lower prices in September, support target 23819 or below.

Ola Electric 2.0: From Scooters to Cells and Rare-Earth-Free Motors

By Nimish Maheshwari

  • Ola secured Auto-PLI compliance for its Gen-3 scooters and guided first deliveries with in-house “Bharat” 4680 cells in Q2 FY26, with heavy rare-earth-free motors in Q3 FY26. 
  • ACC-PLI plus Auto-PLI and insourced cells/motors can lift gross margins structurally, derisk China-centric magnet supply, and shift Ola from assembler to integrated value-chain player.
  • Watch PLI accrual from Q2 FY26, the 1.4→5 GWh cell ramp, and ferrite motor rollout in Q3 FY26. Execution across these will validate the “not just an EV company” narrative.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief India: Maruti Suzuki India, Scoda Tubes, SJS Enterprises Ltd, Aegis Logistics and more

By | Daily Briefs, India

In today’s briefing:

  • Maruti E‑Vitara Launch: Make in India, Make for the World…
  • The Beat Ideas: Scoda Tubes – Ready to Double Capacity, But Can It Deliver?
  • The Beat Ideas: SJS Enterprises, A Niche Premiumisation Play
  • Increased Tariffs -> Decline in Indian Equity Market -> Increased Promoter Activity in August 2025


Maruti E‑Vitara Launch: Make in India, Make for the World…

By Nimish Maheshwari

  • Prime Minister Modi kick‑started production and global dispatch of Maruti Suzuki’s e‑Vitara EV with a “Make in India, Make for the World” pitch.
  • It marks India’s ascent as a global EV manufacturing hub while bolstering local EV infrastructure and Japan‑India industrial synergy.
  • Suzuki is investing INR 70,000 crore (~US$8 billion) over 5–6 years and targeting 50k to 1L units of EV exports each year. 

The Beat Ideas: Scoda Tubes – Ready to Double Capacity, But Can It Deliver?

By Sudarshan Bhandari

  • Scoda Tubes is doubling seamless capacity and scaling welded capacity to 20,068 MTPA and 13,150 MTPA by FY27, with trial runs from H2 FY26.
  • This expansion positions Scoda to grow 2.5–3x industry pace, capture global demand, and strengthen its competitive edge against larger peers.
  • Scoda’s integrated operations and strong export growth improve long-term visibility, making Scoda a potential re-rating candidate. 

The Beat Ideas: SJS Enterprises, A Niche Premiumisation Play

By Sudarshan Bhandari

  • Management reiterated a plan to double revenues in 3–4 years, anchored on premiumisation, global expansion, and synergies from the Walter Pack acquisition.
  • Decorative aesthetics is gaining relevance as OEMs push differentiation via design, while exports de-risk domestic cyclicality.
  • The growth vision is credible, but execution in integrating Walter Pack, sustaining >25% EBITDA margins, and scaling exports to ~15% of sales will determine delivery.

Increased Tariffs -> Decline in Indian Equity Market -> Increased Promoter Activity in August 2025

By Sreemant Dudhoria,CFA

  • In this insight, we detail about insider buying activity in Indian Equities for the month of August 2025.
  • Driven by pressure of increased tariffs, Indian equity market have been underperforming. But as seen in past during such times promoter buying activity increases.
  • This insight details about companies with notable insider buying (large and small caps), sectors which witnessed buying and stocks which trade above and below the insider purchase price.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars